ZSCAN32

Chr 16

zinc finger and SCAN domain containing 32

Also known as: HCCS-5, ZNF434

The ZSCAN32 protein functions as a transcriptional regulator that binds to identical proteins and is predicted to regulate RNA polymerase II transcription in the nucleus. Mutations in this gene cause autosomal recessive developmental and epileptic encephalopathy with microcephaly, affecting neurological development in early childhood. The gene shows tolerance to loss-of-function variants, consistent with the recessive inheritance pattern observed in affected patients.

ResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.57
Clinical SummaryZSCAN32
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 82 VUS of 100 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.57LOEUF
pLI 0.000
Z-score -0.13
OE 1.04 (0.701.57)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.24Z-score
OE missense 1.21 (1.111.33)
324 obs / 266.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.04 (0.701.57)
00.351.4
Missense OE1.21 (1.111.33)
00.61.4
Synonymous OE1.20
01.21.6
LoF obs/exp: 16 / 15.4Missense obs/exp: 324 / 266.8Syn Z: -1.58
DN
0.7130th %ile
GOF
0.6540th %ile
LOF
0.3549th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic4
VUS82
Likely Benign5
4
Pathogenic
82
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
4
0
4
Likely Pathogenic
0
0
0
0
0
VUS
0
73
9
0
82
Likely Benign
0
5
0
0
5
Benign
0
0
0
0
0
Total07813091

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZSCAN32 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found